n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine has been researched along with piroxicam in 1 studies
| Studies (n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine) | Trials (n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine) | Recent Studies (post-2010) (n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine) | Studies (piroxicam) | Trials (piroxicam) | Recent Studies (post-2010) (piroxicam) |
|---|---|---|---|---|---|
| 113 | 0 | 9 | 3,084 | 796 | 704 |
| Protein | Taxonomy | n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine (IC50) | piroxicam (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1.3043 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.1 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saini, MK; Sanyal, SN | 1 |
1 other study(ies) available for n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine and piroxicam
| Article | Year |
|---|---|
Piroxicam and c-phycocyanin prevent colon carcinogenesis by inhibition of membrane fluidity and canonical Wnt/β-catenin signaling while up-regulating ligand dependent transcription factor PPARγ.
Topics: 2-Naphthylamine; Animals; Apoptosis; Calcium; Calpain; Carcinogenesis; Colonic Neoplasms; Fluorescence Polarization; Fura-2; Intracellular Space; Laurates; Ligands; Male; Membrane Fluidity; Membrane Potentials; Phase Transition; Phosphatidylethanolamines; Phycocyanin; Piroxicam; PPAR gamma; Pyrimidinones; Rats, Sprague-Dawley; Up-Regulation; Wnt Signaling Pathway | 2014 |